Persistent URL of this record https://hdl.handle.net/1887/104650
In Collections
This item can be found in the following collections:
![A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG
- All authors
- Smorenburg, C.H.; Groot, S.M. de; Leeuwen-Stok, A.E. van; Hamaker, M.E.; Wymenga, A.N.; Graaf, H. de; Jongh, F.E. de; Braun, J.J.; M. los; Maartense, E.; Tinteren, H. van; Nortier, J.W.R.; Seynaeve, C.
- Date
- 2014-03-31
- Journal
- Annals of Oncology
- Volume
- 25
- Issue
- 3
- Pages
- 599 - 605